載入...
Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
AIMS: Although heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause for hospitalization, its overall costs remain unclear. Therefore, we assessed the health care‐related costs of ambulatory HFpEF patients and the effect of spironolactone. METHODS AND RESULTS: The aldosteron...
Na minha lista:
| 發表在: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261555/ https://ncbi.nlm.nih.gov/pubmed/31984661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12606 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|